The Impact of Glyco-Metabolic Status in Patients Treated for Acute Coronary Syndrome

1. Kamceva G, Vavlukis M, Kitanoski D, Kedev S. Newly Diagnosed Diabetes and Stress Glycaemia and Its’ Association with Acute Coronary Syndrome. Open Access Maced J Med Sci 2015; 3(4): 607-12.10.3889/oamjms.2015.103487789527275295Search in Google Scholar

2. AlNemer KA. Important high light on diabetes in acute coronary syndrome cases: Saudi Arabia. Integrative Molecular Medicine 2016; Volume 3(2): 562-3.10.15761/IMM.1000205Search in Google Scholar

3. Lugg ST, May CJK, Nightingale P, et al. HbA1c screening for new onset diabetes following acute coronary syndrome: is it a worthwhile test in clinical practice? Journal of Diabetes & Metabolic Disorders 2017; 16: 14.10.1186/s40200-017-0296-4Search in Google Scholar

4. Tamita K, Katayama M, Takagi T, et al. Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations. Heart 2012; 98(11): 848-54.10.1136/heartjnl-2012-301629335185322581733Open DOISearch in Google Scholar

5. Lazzeri C, Valente S, Chiostri M, et al. Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. World J Cardiol. 2014; 6(4): 140-7.10.4330/wjc.v6.i4.140399933424772254Open DOISearch in Google Scholar

6. George A, Bhatia RT, Buchanan GL, et al. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study. PLoS ONE 2015; 10(11): e014204510.1371/journal.pone.0142045464662826571120Search in Google Scholar

7. Krinsley JS, Preiser JC, Hirsch IB. Safety and Efficacy of Personalized Glycemic Control in Critically Ill Patients. A 2-Year Before and After Interventional Trial. Endocr Pract. 2017; 23(3): 318-30.10.4158/EP161532.OR27967228Open DOISearch in Google Scholar

8. Angeli F, Verdecchia P, Karthikeyan G, et al. New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis. Curr Diabetes Rev. 2010; 6(2): 102-10.10.2174/15733991079090941320034367Search in Google Scholar

9. Ibanez B, James S, Agewall S, Antunes MJ, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, ehx393, https://doi.org/10.1093/eurheartj/ehx39310.1093/eurheartj/ehx39328886621Open DOISearch in Google Scholar

10. Hyperglycemia in acute coronary syndromes: management. NICE Clinical guideline [CG130] Published date: October 2011. https://www.nice.org.uk/guidance/cg130Search in Google Scholar

11. Wei CH, Litwin SE. Hyperglycemia and Adverse Outcomes in Acute Coronary Syndromes: Is Serum Glucose the Provocateur or Innocent Bystander? Diabetes 2014; 63(7): 2209-12.10.2337/db14-057124962919Open DOISearch in Google Scholar

12. Chiang FT, Shyu KG, Wu CJ, et al. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry. Journal of the Formosan Medical Association 2014; Vol 113 (11): 794-802.10.1016/j.jfma.2013.08.00124076272Search in Google Scholar